Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2012-11-19 |
| Study Made Public: | 2014-10-06 |
Title
Weiss_Boger_UCL_VDC_NHP
Description
CAVD 393 is a non-human primate challenge study comparing protein regimens.
Sign in to see full information about this study and to download study data.
Products
MF59 gp120 V1/V2 A244 Carbopol 974P gp120 V3 CN54 gp140 CA18 gp41 HXB2 SHIV-SF162P3Integrated data
NAb
Non-integrated data
No non-integrated data is available for this study.